{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:39:42Z","timestamp":1792136382418,"version":"4.4.0"},"reference-count":152,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Interactions of drugs with the classical epigenetic mechanism of DNA methylation or histone modification are increasingly being elucidated mechanistically and used to develop novel classes of epigenetic therapeutics. A data science approach is used to synthesize current knowledge on the pharmacological implications of epigenetic regulation of gene expression. Computer-aided knowledge discovery for epigenetic implications of current approved or investigational drugs was performed by querying information from multiple publicly available gold-standard sources to (i) identify enzymes involved in classical epigenetic processes, (ii) screen original biomedical scientific publications including bibliometric analyses, (iii) identify drugs that interact with epigenetic enzymes, including their additional non-epigenetic targets, and (iv) analyze computational functional genomics of drugs with epigenetic interactions. PubMed database search yielded 3051 hits on epigenetics and drugs, starting in 1992 and peaking in 2016. Annual citations increased to a plateau in 2000 and show a downward trend since 2008. Approved and investigational drugs in the DrugBank database included 122 compounds that interacted with 68 unique epigenetic enzymes. Additional molecular functions modulated by these drugs included other enzyme interactions, whereas modulation of ion channels or G-protein-coupled receptors were underrepresented. Epigenetic interactions included (i) drug-induced modulation of DNA methylation, (ii) drug-induced modulation of histone conformations, and (iii) epigenetic modulation of drug effects by interference with pharmacokinetics or pharmacodynamics. Interactions of epigenetic molecular functions and drugs are mutual. Recent research activities on the discovery and development of novel epigenetic therapeutics have passed successfully, whereas epigenetic effects of non-epigenetic drugs or epigenetically induced changes in the targets of common drugs have not yet received the necessary systematic attention in the context of pharmacological plasticity.<\/jats:p>","DOI":"10.3390\/ijms22147250","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T11:36:44Z","timestamp":1625571404000},"page":"7250","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Drugs and Epigenetic Molecular Functions. A Pharmacological Data Scientometric Analysis"],"prefix":"10.3390","volume":"22","author":[{"given":"Dario","family":"Kringel","sequence":"first","affiliation":[{"name":"Institute of Clinical Pharmacology, Goethe-University, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6766-140X","authenticated-orcid":false,"given":"Sebastian","family":"Malkusch","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology, Goethe-University, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5818-6958","authenticated-orcid":false,"given":"J\u00f6rn","family":"L\u00f6tsch","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology, Goethe-University, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany"},{"name":"Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000323874","article-title":"Epigenetics: Principles and Practice","volume":"29","author":"Hamilton","year":"2011","journal-title":"Dig. Dis."},{"key":"ref_2","first-page":"367","article-title":"Cancer\u2019s epigenetic drugs: Where are they in the cancer medicines?","volume":"20","author":"Ghasemi","year":"2020","journal-title":"Pharm. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.molmed.2013.08.006","article-title":"Common non-epigenetic drugs as epigenetic modulators","volume":"19","author":"Schneider","year":"2013","journal-title":"Trends Mol. Med."},{"key":"ref_4","first-page":"478","article-title":"Royalactin induces queen differentiation in honeybees","volume":"473","author":"Kamakura","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1158\/0008-5472.CAN-06-2995","article-title":"Changes in DNA Methylation Patterns in Subjects Exposed to Low-Dose Benzene","volume":"67","author":"Bollati","year":"2007","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ebiom.2018.10.051","article-title":"Epigenetic signatures of starting and stopping smoking","volume":"37","author":"McCartney","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1057\/biosoc.2011.1","article-title":"Food as exposure: Nutritional epigenetics and the new metabolism","volume":"6","author":"Landecker","year":"2011","journal-title":"BioSocieties"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000503289","article-title":"Epigenetic Modifications as Outcomes of Exercise Interventions Related to Specific Metabolic Alterations: A Systematic Review","volume":"12","author":"Milagro","year":"2019","journal-title":"Lifestyle Genom."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1126\/science.277.5332.1659","article-title":"Maternal Care, Hippocampal Glucocorticoid Receptors, and Hypothalamic-Pituitary-Adrenal Responses to Stress","volume":"277","author":"Liu","year":"1997","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nn1276","article-title":"Epi-genetic programming by maternal behavior","volume":"7","author":"Weaver","year":"2004","journal-title":"Nat. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/mp.2014.80","article-title":"Pathological brain plasticity and cognition in the offspring of males subjected to postnatal traumatic stress","volume":"20","author":"Bohacek","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.neuron.2012.01.012","article-title":"Chronic Pain: Emerging Evidence for the Involvement of Epigenetics","volume":"73","author":"Denk","year":"2012","journal-title":"Neuron"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1128\/MCB.01768-08","article-title":"Monometh-ylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development","volume":"29","author":"Oda","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrn3111","article-title":"Transcriptional and epigenetic mechanisms of addiction","volume":"12","author":"Robison","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"107ra109","DOI":"10.1126\/scitranslmed.3003062","article-title":"Molecular Mechanism for a Gateway Drug: Epigenetic Changes Initiated by Nicotine Prime Gene Expression by Cocaine","volume":"3","author":"Levine","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12031-012-9829-y","article-title":"Ethanol Induces Epigenetic Modulation of Prodynorphin and Pronociceptin Gene Expression in the Rat Amygdala Complex","volume":"49","author":"Caputi","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/15592294.2015.1055441","article-title":"Epigenetic landscape of amphetamine and methamphetamine addiction in rodents","volume":"10","author":"Godino","year":"2015","journal-title":"Epigenetics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pain.2012.06.011","article-title":"Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain","volume":"154","author":"Doehring","year":"2013","journal-title":"Pain"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2217\/epi.15.78","article-title":"Methadone induces hypermethylation of human DNA","volume":"8","author":"Knothe","year":"2015","journal-title":"Epigenomics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/carcin\/bgh209","article-title":"Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-gene in rat colon tumors","volume":"25","author":"Pereira","year":"2004","journal-title":"Carcinogenesis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Minucci","year":"2001","journal-title":"EMBO J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/bioinformatics\/btn615","article-title":"AmiGO: Online access to ontology and annotation data","volume":"25","author":"Carbon","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: A Major Update to the DrugBank Database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene Ontology: Tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Huang, Z., Jiang, H., Liu, X., Chen, Y., Wong, J., Wang, Q., Huang, W., Shi, T., and Zhang, J. (2012). HEMD: An integrated tool of hu-man epigenetic enzymes and chemical modulators for therapeutics. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039917"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"D514","DOI":"10.1093\/nar\/gkq892","article-title":"genenames.org: The HGNC resources in 2011","volume":"39","author":"Seal","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/nar\/27.1.29","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"27","author":"Ogata","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_29","unstructured":"R Development Core Team (2018). R: A Language and Environment for Statistical Computing, R Core Team. Available online: https:\/\/www.r-project.org\/."},{"key":"ref_30","unstructured":"(2021). UniProt: The universal protein knowledgebase in 2021. Nucleic Acids Res., 49, D480\u2013D489."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0006-291X(05)80315-8","article-title":"Genomic differences between O6-methylguanine-DNA methyltransferase proficient (Mex+) and deficient (Mex\u2212) cell lines: Possible role of genetic and epigenetic changes in conversion of Mex+ into Mex\u2212","volume":"183","author":"Fritz","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e00300","DOI":"10.1016\/j.heliyon.2017.e00300","article-title":"Citation analysis of scientific categories","volume":"3","author":"Patience","year":"2017","journal-title":"Heliyon"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/5047","article-title":"Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer","volume":"21","author":"Cameron","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1073\/pnas.0400280101","article-title":"From The Cover: Diffusion-based method for producing density-equalizing maps","volume":"101","author":"Gastner","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Wickham, H. (2009). ggplot2: Elegant Graphics for Data Analysis, Springer.","DOI":"10.1007\/978-0-387-98141-3"},{"key":"ref_37","unstructured":"Lang, D.T. (2021, April 22). R Cartogram: Interface to Mark Newman\u2019s Cartogram Software. Available online: https:\/\/www.swmath.org\/software\/20868."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3324\/haematol.2016.154377","article-title":"Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: Results of a phase II study","volume":"102","author":"Ribrag","year":"2017","journal-title":"Haematologica"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1358\/dot.2007.43.6.1062666","article-title":"DNA methyltransferase as targets for cancer therapy","volume":"43","author":"Ghoshal","year":"2007","journal-title":"Drugs Today"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wong, C.P., Hsu, A., Buchanan, A., Palomera-Sanchez, Z., Beaver, L.M., Houseman, E.A., Williams, D.E., Dashwood, R.H., and Ho, E. (2014). Effects of Sulforaphane and 3,3\u2032-Diindolylmethane on Genome-Wide Promoter Methylation in Normal Prostate Epithelial Cells and Prostate Cancer Cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0086787"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1200\/JCO.2011.41.2395","article-title":"Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I\/II study with bi-omarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeu-tics Research Group","volume":"30","author":"Yeo","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1038\/bcj.2015.37","article-title":"The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells","volume":"5","author":"Lai","year":"2015","journal-title":"Blood Cancer J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10637-017-0552-y","article-title":"Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK\/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway","volume":"36","author":"Zhou","year":"2018","journal-title":"Investig. New Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Hoffman, M.M., Zylla, J.S., Bhattacharya, S., Calar, K., Hartman, T.W., Bhardwaj, R.D., Miskimins, W.K., De La Puente, P., Gnimpieba, E.Z., and Messerli, S.M. (2020). Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid\/Rhabdoid. Cancers, 12.","DOI":"10.3390\/cancers12030756"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bjc.2011.527","article-title":"Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours","volume":"106","author":"Pili","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2141.2010.08266.x","article-title":"A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms","volume":"150","author":"Rambaldi","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/art.30238","article-title":"Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis","volume":"63","author":"Vojinovic","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wong, K.K., Lawrie, C.H., and Green, T.M. (2019). Oncogenic Roles and Inhibitors of DNMT1, DNMT3A, and DNMT3B in Acute Myeloid Leukaemia. Biomark. Insights, 14.","DOI":"10.1177\/1177271919846454"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00262-017-2091-y","article-title":"The class I\/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy","volume":"67","author":"Briere","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"LaBonte, M.J., Wilson, P.M., Fazzone, W., Groshen, S., Lenz, H.J., and Ladner, R.D. (2009). DNA microarray profiling of genes differen-tially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines. BMC Med. Genom., 2.","DOI":"10.1186\/1755-8794-2-67"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"16862","DOI":"10.1038\/s41598-019-53239-6","article-title":"The DOT1L inhibitor Pinometostat decreases the host-response against infections: Considerations about its use in human therapy","volume":"9","author":"Nieto","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"117469","DOI":"10.1016\/j.lfs.2020.117469","article-title":"Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6\/STAT3 signalling pathways","volume":"248","author":"Chen","year":"2020","journal-title":"Life Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.7150\/ijbs.27661","article-title":"The HDAC Inhibitor Quisino-stat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0\/G1 phase arrest and Apoptosis induction","volume":"14","author":"He","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2141.2010.08124.x","article-title":"The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells","volume":"149","author":"Meinel","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/1078-0432.CCR-16-2526","article-title":"Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma","volume":"23","author":"Vogl","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1586\/era.10.88","article-title":"Romidepsin: A new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors","volume":"10","author":"Grant","year":"2010","journal-title":"Expert Rev. Anticancer. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Soldi, R., Ghosh Halder, T., Weston, A., Thode, T., Drenner, K., Lewis, R., Kaadige, M.R., Srivastava, S., Daniel Ampanattu, S., and Rodriguez Del Villar, R. (2020). The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch\/Sucrose-NonFermentable (SWI\/SNF) complex mutated ovarian cancer. PLoS ONE, 15.","DOI":"10.1101\/2020.01.10.902528"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1158\/1940-6207.CAPR-14-0459","article-title":"Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy","volume":"8","author":"Cipolla","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1358\/dot.2020.56.6.3147937","article-title":"Tazemetostat for the treatment of multiple types of hematological malignancies and solid tumors","volume":"56","author":"Marsh","year":"2020","journal-title":"Drugs Today"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/13543784.16.7.1111","article-title":"Vorinostat: A new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma","volume":"16","author":"Duvic","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11010-011-1019-7","article-title":"Epigenetic changes by zebu-larine leading to enhanced differentiation of human promyelocytic leukemia NB4 and KG1 cells","volume":"359","author":"Savickiene","year":"2012","journal-title":"Mol. Cell Biochem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"112627","DOI":"10.1016\/j.bbr.2020.112627","article-title":"CBD modulates DNA methylation in the prefrontal cortex and hippocampus of mice exposed to forced swim","volume":"388","author":"Sales","year":"2020","journal-title":"Behav. Brain Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1073\/pnas.1015483108","article-title":"Cocaine dynamically regulates heterochromatin and repeti-tive element unsilencing in nucleus accumbens","volume":"108","author":"Maze","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/pros.21247","article-title":"Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth","volume":"71","author":"Lin","year":"2011","journal-title":"Prostate"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1017\/S1461145711000940","article-title":"Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression","volume":"15","author":"Melas","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/neu.2010.1648","article-title":"Fluoxetine Increases Hippocampal Neurogenesis and Induces Epigenetic Factors But Does Not Improve Functional Recovery after Traumatic Brain Injury","volume":"28","author":"Wang","year":"2011","journal-title":"J. Neurotrauma"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/mol.106.022301","article-title":"Fluoxetine and Cocaine Induce the Epigenetic Factors MeCP2 and MBD1 in Adult Rat Brain","volume":"70","author":"Cassel","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Schafer, A., Schomacher, L., Barreto, G., D\u00f6derlein, G., and Niehrs, C. (2010). Gemcitabine Functions Epigenetically by Inhibiting Repair Mediated DNA Demethylation. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0014060"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1479-5876-4-10","article-title":"Hydralazine tar-get: From blood vessels to the epigenome","volume":"4","author":"Arce","year":"2006","journal-title":"J. Transl. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/cmdc.200900017","article-title":"Molecular modeling and molecular dynamics studies of hy-dralazine with human DNA methyltransferase 1","volume":"4","author":"Singh","year":"2009","journal-title":"ChemMedChem"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1038\/bcj.2011.33","article-title":"Imatinib causes epigenetic alterations of PTEN gene via upregu-lation of DNA methyltransferases and polycomb group proteins","volume":"1","author":"Nishioka","year":"2011","journal-title":"Blood Cancer J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2217\/epi-2016-0072","article-title":"Phar-macoepigenetics of the role of DNA methylation in mu-opioid receptor expression in different human brain regions","volume":"8","author":"Knothe","year":"2016","journal-title":"Epige-nomics"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"17454","DOI":"10.1523\/JNEUROSCI.1357-12.2012","article-title":"Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus ac-cumbens","volume":"32","author":"Sun","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Stone, A., Valdes-Mora, F., Gee, J.M.W., Farrow, L., McClelland, R.A., Fiegl, H., Dutkowski, C., McCloy, R.A., Sutherland, R.L., and Musgrove, E.A. (2012). Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0040466"},{"key":"ref_75","first-page":"971","article-title":"Trichostatin A is a histone deacetylase in-hibitor with potent antitumor activity against breast cancer in vivo","volume":"7","author":"Vigushin","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1038\/sj.onc.1205600","article-title":"CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future","volume":"21","author":"Esteller","year":"2002","journal-title":"Oncogene"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1158\/1078-0432.CCR-08-2783","article-title":"Targeting DNA Methylation","volume":"15","author":"Issa","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1517\/13543784.16.5.659","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"16","author":"Rasheed","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1158\/1535-7163.MCT-06-0022","article-title":"Vorinostat, a histone deacetylase inhibitor, en-hances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci","volume":"5","author":"Munshi","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"ref_81","first-page":"84","article-title":"Farydak (Panobinostat): First HDAC Inhibitor Approved for Patients with Relapsed Multiple Myeloma","volume":"9","author":"Raedler","year":"2016","journal-title":"Am. Health Drug Benefits"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1634\/theoncologist.2017-0301","article-title":"EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and\/or Refractory Multiple Myeloma","volume":"23","author":"Tzogani","year":"2018","journal-title":"Oncologist"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/02688697.2011.638996","article-title":"Effect of valproic acid on the out-come of glioblastoma multiforme","volume":"26","author":"Tsai","year":"2012","journal-title":"Br. J. Neurosurg."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00280-015-2695-x","article-title":"Phase I trial of valproic acid and lenalidomide in patients with advanced cancer","volume":"75","author":"Bilen","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1055\/s-0038-1676303","article-title":"Impacts of Cytochrome P450 2D6 (CYP2D6) Genetic Polymorphism in Tamoxifen Therapy for Breast Cancer","volume":"40","author":"Bezerra","year":"2018","journal-title":"Rev. Bras. Ginecol. Obs. RBGO Gynecol. Obstet."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.apsb.2012.01.001","article-title":"Epigenetic regulation of developmental expression of Cyp2d genes in mouse liver","volume":"2","author":"Li","year":"2012","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/FPC.0b013e32832e0eac","article-title":"Codeine and morphine pathway","volume":"19","author":"Thorn","year":"2009","journal-title":"Pharm. Genom."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Taylor, C., Crosby, I., Yip, V., Maguire, P., Pirmohamed, M., and Turner, R.M. (2020). A Review of the Important Role of CYP2D6 in Pharmacogenomics. Genes, 11.","DOI":"10.3390\/genes11111295"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.apsb.2015.01.007","article-title":"Epigenetic regulation of drug metabolism and transport","volume":"5","author":"Peng","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: The NCBI database of ge-netic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1093\/hmg\/dds314","article-title":"Genetic-epigenetic interaction modulates mu-opioid receptor regulation","volume":"21","author":"Oertel","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/15622975.2013.866693","article-title":"The Tutsi genocide and transgenerational transmission of maternal stress: Epigenetics and biology of the HPA axis","volume":"15","author":"Perroud","year":"2014","journal-title":"World J. Biol. Psychiatry"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1176\/appi.ajp.2014.13121571","article-title":"Influences of Maternal and Paternal PTSD on Epigenetic Regulation of the Glucocorticoid Receptor Gene in Holocaust Survivor Offspring","volume":"171","author":"Yehuda","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1038\/tp.2014.3","article-title":"Epigenetic modulation of glucocorticoid receptors in posttrau-matic stress disorder","volume":"4","author":"Azoulay","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"20502","DOI":"10.1074\/jbc.M114.569889","article-title":"Loss of TBL1XR1 Disrupts Glucocorticoid Receptor Recruitment to Chromatin and Results in Glucocorticoid Resistance in a B-Lymphoblastic Leukemia Model*","volume":"289","author":"Jones","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s40265-018-0927-1","article-title":"Fostamatinib: First Global Approval","volume":"78","author":"Markham","year":"2018","journal-title":"Drugs"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3389\/fphar.2019.00897","article-title":"Efficacy and Safety of Multiple Dosages of Fostamatinib in Adult Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis","volume":"10","author":"Kang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1358\/dot.2007.43.9.1112980","article-title":"Vorinostat in cutaneous T-cell lymphoma","volume":"43","author":"Duvic","year":"2007","journal-title":"Drugs Today"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1021\/jm00008a020","article-title":"The synthesis of N-hydroxy-N\u2019-phenyloctanediamide and its inhibitory effect on pro-liferation of AXC rat prostate cancer cells","volume":"38","author":"Stowell","year":"1995","journal-title":"J. Med. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2009.01.002","article-title":"Development of vorinostat: Current applications and future perspectives for cancer therapy","volume":"280","author":"Richon","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/COH.0b013e32835ef089","article-title":"Combined approaches for HIV cure","volume":"8","author":"Margolis","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_103","first-page":"7412","article-title":"Vori-nostat as potential antiparasitic drug","volume":"24","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_104","first-page":"385","article-title":"On the propyl derivatives and decomposition products of ethylacetoacetate","volume":"3","author":"Burton","year":"1882","journal-title":"Am. Chem. J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(15)00398-1","article-title":"The remarkable story of valproic acid","volume":"15","author":"Tomson","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1528-1157.1975.tb04738.x","article-title":"Sodium Di-N-Propylacetate (DPA) in the Treatment of Epilepsy: A Review","volume":"16","author":"Simon","year":"1975","journal-title":"Epilepsia"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.311.7012.1047","article-title":"Anticonvulsant drugs for management of pain: A systematic re-view","volume":"311","author":"McQuay","year":"1995","journal-title":"BMJ"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1365-2044.1981.tb08701.x","article-title":"Anticonvulsant drugs used in the treatment of lancinating pain. A comparison","volume":"36","author":"Swerdlow","year":"1981","journal-title":"Anaesthesia"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1600-0404.2003.00178.x","article-title":"Sodium valproate in painful diabetic polyneuropathy","volume":"108","author":"Sindrup","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"De Caro, C., Mannelli, L.D.C., Branca, J.J.V., Micheli, L., Citraro, R., Russo, E., De Sarro, G., Ghelardini, C., Calignano, A., and Russo, R. (2020). Pain Modulation in WAG\/Rij Epileptic Rats (A Genetic Model of Absence Epilepsy): Effects of Biological and Pharmacological Histone Deacetylase Inhibitors. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.549191"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"Zhu","year":"2003","journal-title":"EMBO J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/STROKEAHA.117.016674","article-title":"Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack","volume":"49","author":"Brookes","year":"2018","journal-title":"Stroke"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Ultsch, A., and L\u00f6tsch, J. (2014). Functional Abstraction as a Method to Discover Knowledge in Gene Ontologies. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090191"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Thulasiraman, K., and Swamy, M.N.S. (1992). Graphs: Theory and Algorithms, Wiley.","DOI":"10.1002\/9781118033104"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Ultsch, A., and L\u00f6tsch, J. (2015). Computed ABC Analysis for Rational Selection of Most Informative Variables in Multivariate Data. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129767"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2217\/pgs-2018-0036","article-title":"Computational functional genomics-based approaches in analgesic drug discovery and repurposing","volume":"19","author":"Lippmann","year":"2018","journal-title":"Pharmacogenomics"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N","article-title":"An open graph visualization system and its applications to software engineering","volume":"30","author":"Gansner","year":"2000","journal-title":"Softw. Pract. Exp."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/bph.12309","article-title":"Epigenetic control of skin differentiation genes by phytocannabinoids","volume":"170","author":"Pucci","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_119","first-page":"157","article-title":"On the Criterion that a Given System of Deviations from the Probable in the Case of a Correlated System of Variables is Such that it Can be Reasonably Supposed to have Arisen from Random Sampling","volume":"50","author":"Pearson","year":"1900","journal-title":"Linear Gen. Linear Mixed Models Appl."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/BOR.0000000000000128","article-title":"Epigenetics in rheumatoid arthritis","volume":"27","author":"Klein","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e00532","DOI":"10.1002\/prp2.532","article-title":"Pharmacological plasticity-How do you hit a moving target?","volume":"7","author":"Parnham","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13148-015-0143-8","article-title":"Imprinting disorders: A group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci","volume":"7","author":"Eggermann","year":"2015","journal-title":"Clin. Epigenetics"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41576-018-0092-0","article-title":"Genomic imprinting disorders: Lessons on how genome, epigenome and environment interact","volume":"20","author":"Monk","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/jmedgenet-2017-105190","article-title":"Maternal variants in NLRP and other maternal effect proteins are associated with multilocus imprinting disturbance in offspring","volume":"55","author":"Begemann","year":"2018","journal-title":"J. Med. Genet."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13073-019-0694-y","article-title":"A KHDC3L mutation resulting in recurrent hydatidiform mole causes genome-wide DNA methylation loss in oocytes and persistent imprinting defects post-fertilisation","volume":"11","author":"Demond","year":"2019","journal-title":"Genome Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13148-019-0760-8","article-title":"The phenotypic variations of multi-locus imprinting disturbances associated with maternal-effect variants of NLRP5 range from overt imprinting disorder to apparently healthy phenotype","volume":"11","author":"Sparago","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tig.2016.05.001","article-title":"Causes and Consequences of Multi-Locus Imprinting Disturbances in Humans","volume":"32","author":"Riccio","year":"2016","journal-title":"Trends Genet."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13148-020-00925-2","article-title":"Loss-of-function maternal-effect mutations of PADI6 are associated with familial and sporadic Beckwith-Wiedemann syndrome with multi-locus imprinting disturbance","volume":"12","author":"Cubellis","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/jcrpe.galenos.2019.2018.0249","article-title":"Syndromic Disorders Caused by Disturbed Human Imprinting","volume":"12","author":"Carli","year":"2020","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"ref_130","first-page":"321","article-title":"Clinical spectrum and management of imprinting disorders","volume":"32","author":"Elbracht","year":"2020","journal-title":"Med. Genet."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.trsl.2019.02.012","article-title":"Epigenetic therapy of Prader-Willi syndrome","volume":"208","author":"Kim","year":"2019","journal-title":"Transl. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13023-015-0273-2","article-title":"Drug repositioning can accelerate discovery of pharmacological chaperones","volume":"10","author":"Mele","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tips.2021.01.003","article-title":"Drug Repurposing for Rare Diseases","volume":"42","author":"Roessler","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.therap.2020.02.007","article-title":"Drug repositioning for rare diseases: Knowledge-based success stories","volume":"75","author":"Scherman","year":"2020","journal-title":"Therapie"},{"key":"ref_135","first-page":"252","article-title":"Integrated computational analysis of genes associated with human hereditary insensitivity to pain. A drug repurposing perspective","volume":"10","author":"Lippmann","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/psp4.12072","article-title":"Process Pharmacology: A Pharmacological Data Science Approach to Drug Development and Therapy","volume":"5","author":"Ultsch","year":"2016","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.neubiorev.2015.05.016","article-title":"Glucocorticoid receptor gene (NR3C1) methylation pro-cesses as mediators of early adversity in stress-related disorders causality: A critical review","volume":"55","author":"Leza","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1192\/bjb.2020.18","article-title":"Kevin Mitchell","volume":"44","author":"McKenna","year":"2020","journal-title":"BJPsych Bull."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2009.07.023","article-title":"Are we getting anywhere in human pain genetics?","volume":"146","author":"Mogil","year":"2009","journal-title":"Pain"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-genet-120417-031404","article-title":"Transgenerational Epigenetic Inheritance","volume":"52","author":"Rando","year":"2018","journal-title":"Annu. Rev. Genet."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"R: A Language for Data Analysis and Graphics","volume":"5","author":"Ihaka","year":"1996","journal-title":"J. Comput. Graph. Stat."},{"key":"ref_142","unstructured":"Lang, D.T. (2021, April 22). XML: Tools for Parsing and Generating XML within R and S-Plus. Available online: https:\/\/cran.r-project.org\/web\/packages\/XML\/index.html."},{"key":"ref_143","unstructured":"Carlson, M. (2021, April 22). org.Hs.eg.db: Genome Wide Annotation for Human. Available online: https:\/\/bioconductor.org\/packages\/org.Hs.eg.db\/."},{"key":"ref_144","unstructured":"Kovalchik, S. (2021, April 22). RISmed: Download Content from NCBI Databases. Available online: https:\/\/cran.r-project.org\/package=RISmed."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13643-018-0819-1","article-title":"A review of recent publication trends from top publishing countries","volume":"7","author":"Fontelo","year":"2018","journal-title":"Syst. Rev."},{"key":"ref_146","unstructured":"Ali, M., and Ezzat, A. (2021, April 22). DrugBank Database XML Parser. Available online: https:\/\/cran.r-project.org\/package=dbparser."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"D262","DOI":"10.1093\/nar\/gkh021","article-title":"The Gene Ontology Annotation (GOA) Database: Sharing knowledge in Uniprot with Gene Ontology","volume":"32","author":"Camon","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1101\/gr.461403","article-title":"The Gene Ontology Annotation (GOA) Project: Implementation of GO in SWISS-PROT, TrEMBL, and InterPro","volume":"13","author":"Camon","year":"2003","journal-title":"Genome Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fgene.2020.00654","article-title":"Gene Set Analysis: Challenges, Opportunities, and Future Research","volume":"11","author":"Maleki","year":"2020","journal-title":"Front. Genet."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2307\/2340521","article-title":"On the Interpretation of Chi Square from Contingency Tables, and the Calculation of P","volume":"85","author":"Fisher","year":"1922","journal-title":"J. R. Stat. Soc."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","article-title":"A Sharper Bonferroni Procedure for Multiple Tests of Significance","volume":"75","author":"Hochberg","year":"1988","journal-title":"Biometrika"},{"key":"ref_152","unstructured":"Carlson, M. (2021, April 22). GO.db: A Set of Annotation Maps Describing the Entire Gene Ontology. Available online: http:\/\/bioconductor.org\/packages\/GO.db\/."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7250\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:26:34Z","timestamp":1760163994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":152,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22147250"],"URL":"https:\/\/doi.org\/10.3390\/ijms22147250","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]}}}